We are live on
!
Find out more
VIA
Vantis Investment Advisers Portfolio holdings
AUM
$96.6M
1-Year Est. Return
2.92%
This Fund
S&P 500
This Quarter
Est. Return
+21.51%
1 Year Est. Return
+2.92%
3 Year Est. Return
+39.64%
5 Year Est. Return
+43.64%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$96.8M
(+408%)
Cap. Flow
+$91.3M
Cap. Flow
% of AUM
75.74%
Top 10 Holdings %
Top 10 Hldgs %
83.52%
Holding
19
New
14
Increased
–
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$16.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$13.3M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$10.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$9.96M |
| 5 |
Verizon
VZ
|
+$9.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$7.15M |
| 2 |
Uber
UBER
|
+$6.05M |
| 3 |
Walt Disney
DIS
|
+$4.09M |
| 4 |
Target
TGT
|
+$2.42M |
| 5 |
LAC
Lithium Americas Corp. Common Shares
LAC
|
+$817K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.73% |
| 2 | Technology | 25.27% |
| 3 | Consumer Staples | 11.43% |
| 4 | Communication Services | 7.82% |
| 5 | Industrials | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Advanced Micro Devices
AMD
$776B
| $16.7M | 13.85% |
+317,400
| New | +$16.8M |
|
|
2
Regeneron Pharmaceuticals
REGN
$78.5B
| $14.7M | 12.16% |
+23,500
| New | +$13.3M |
|
|
IPHI
3
DELISTED
INPHI CORPORATION
IPHI
| $11.5M | 9.57% |
+98,200
| New | +$10.3M |
|
|
4
Bristol-Myers Squibb
BMY
$133B
| $9.79M | 8.12% |
+166,500
| New | +$9.96M |
|
|
5
Verizon
VZ
$195B
| $9.43M | 7.82% |
+171,000
| New | +$9.62M |
|
6
Micron Technology
MU
$930B
| $9.34M | 7.74% |
+181,200
| New | +$8.54M |
|
7
Walmart Inc
WMT
$885B
| $9.05M | 7.51% |
+226,800
| New | +$9.33M |
|
8
Eli Lilly
LLY
$1.02T
| $7.66M | 6.36% |
+46,680
| New | +$7.17M |
|
9
Honeywell
HON
$77B
| $6.26M | 5.19% |
+45,941
| New | +$6.08M |
|
|
FLIR
10
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $6.26M | 5.19% |
+154,200
| New | +$6.4M |
|
|
11
Target
TGT
$65.6B
| $4.72M | 3.92% |
39,400
-21,200
| -35% | -$2.42M |
|
12
Marvell Technology
MRVL
$168B
| $4.42M | 3.67% |
+126,200
| New | +$3.69M |
|
13
Avantor
AVTR
$9.32B
| $4.29M | 3.56% |
+252,100
| New | +$4.1M |
|
14
Johnson & Johnson
JNJ
$618B
| $4.26M | 3.53% |
+30,300
| New | +$4.42M |
|
|
B
15
Barrick Mining
B
$61.5B
| $2.17M | 1.8% |
+80,600
| New | +$2.01M |
|
|
16
Walt Disney
DIS
$167B
| – | – |
-42,300
| Closed | -$4.09M |
|
|
17
Gilead Sciences
GILD
$162B
| – | – |
-95,600
| Closed | -$7.15M |
|
|
18
Uber
UBER
$143B
| – | – |
-216,800
| Closed | -$6.05M |
|
|
LAC
19
DELISTED
Lithium Americas Corp. Common Shares
LAC
| – | – |
-307,100
| Closed | -$817K |
|
Similar funds
CG1
ST
MI
SCC
MTM
LMAM
MCS
HCIL
Vantis Investment Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, Vantis Investment Advisers held 19 positions worth $121M, up 408% from $23.7M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Vantis Investment Advisers deployed $91.3M of net new capital in Q2 2020, opening 14 new positions. Its largest new stake was Advanced Micro Devices: 317,400 shares worth $16.7M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Target, an estimated $2.42M trimmed.
- Vantis Investment Advisers's largest Q2 2020 buy was Advanced Micro Devices: 317,400 shares worth $16.7M.
- Vantis Investment Advisers's biggest Q2 2020 reduction was Target, cutting an estimated $2.42M.
- Vantis Investment Advisers fully exited Gilead Sciences in Q2 2020, selling an estimated $7.15M.
- Vantis Investment Advisers's ten largest holdings make up 84% of its $121M portfolio in Q2 2020.
- Vantis Investment Advisers opened 14 new positions and closed 4 in Q2 2020.
- Vantis Investment Advisers's portfolio value rose 408% quarter-over-quarter to $121M.
Based on Vantis Investment Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.